This week’s article highlights the contribution of T cell reactivity to nonviral antigens to the success of adoptive T cell transfer in treating a virus-driven cancer.
IMMUNOTHERAPY
Targeting nonviral antigens in viral-driven cancer
Stevanović et al. report that reactive T cells directed against nonviral antigens lead to regression of human papilloma virus–positive cervical cancer.